TriSalus Announces New Executive Appointments to Propel Growth in Oncology Innovation
Portfolio - People | Jan 08, 2025 | Tullis-Dickerson & Co Inc
TriSalus Life Sciences, an oncology company focused on innovative therapies for solid tumors, has announced pivotal leadership changes to sustain its growth momentum. As of January 6, 2025, the company appointed James Young as CFO, Richard Marshak as Chief Commercial Officer, and Jodi Devlin as Chief of Clinical Strategy and Operations. The former CFO, Sean Murphy, remains in a high-level strategic role and on the board. These changes underscore TriSalus' commitment to leverage its Pressure-Enabled Drug Delivery technology and the investigational drug nelitolimod in improving patient outcomes. CEO Mary Szela emphasized the importance of these appointments in realizing the company's 2025 goals and maintaining its clinical and commercial excellence.
Sectors
- Biotechnology
- Pharmaceuticals
- Healthcare
Geography
- United States – TriSalus Life Sciences is based in Denver, USA, and collaborates with cancer centers across the country.
Industry
- Biotechnology – TriSalus Life Sciences operates in the biotechnology industry, focusing on drug delivery technology and investigational immunotherapy for cancer treatment.
- Pharmaceuticals – The company's focus on developing innovative cancer therapies places it within the pharmaceuticals sector, particularly related to oncology.
- Healthcare – By providing treatments for solid tumors and partnering with leading cancer centers, TriSalus is also part of the broader healthcare industry.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| TriSalus Life Sciences, Inc. | Target company | Company | An oncology company focused on improving cancer treatment outcomes through innovative delivery technologies. |
| Tullis-Dickerson & Co Inc. | PE Firm | Company | The private equity firm associated with TriSalus Life Sciences. |
| James Young | Chief Financial Officer | Person | Recently appointed CFO of TriSalus, previously Senior Vice President of Investor Relations and Treasurer. |
| Richard Marshak | Chief Commercial Officer | Person | Promoted to CCO from his role as Senior VP of Corporate Development, Strategy, and Marketing. |
| Jodi Devlin | Chief of Clinical Strategy and Operations | Person | Promoted to lead clinical strategy, previously President of Commercial Operations at TriSalus. |
| Sean Murphy | Chief Manufacturing, Strategy and Business Development Officer | Person | Former CFO who continues to serve in strategic roles and as a board member. |
| Mary Szela | President and Chief Executive Officer | Person | CEO of TriSalus, overseeing the company's strategic direction and growth initiatives. |